Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MCOV-B.STthis companyMedicover AB (publ)	SEK 264.00	39.79×	5.74×	1.29×	11.69×	-51.7%	23.2%	6.5%	3.3%	14.5%	5.6%	6.1%	2.7×	3.59×	2.43×	0.7×	0.7%	6	2.36	2	B-
AMBEA.STAmbea AB (publ)	SEK 192.90	17.77×	2.27×	0.74×	8.99×	310.1%	17.5%	7.5%	4.1%	12.8%	5.1%	17.2%	2.43×	4.62×	2.31×	0.41×	1.6%	6	1.38	3	B+
ATT.STAttendo AB (publ)	SEK 127.10	15.03×	2.24×	0.64×	7.08×	306.6%	16.9%	9.2%	4.3%	14.9%	6.2%	21.6%	3.02×	3.92×	2.14×	0.76×	1.5%	6	1.46	4	A-
BIOVIC-B.STBiovica International AB (publ)	SEK 0.32	-1.17×	0.95×	6.14×	-0.26×	-1052.3%	-523.5%	-523.5%	-522.1%	-80.9%	-76.5%	-77.0%	0.05×	1.07×	-176.89×	4.3×	0.0%	3	-9.24	2	C
BOUL.STBoule Diagnostics AB	SEK 1.22	-49.1×	1.11×	0.38×	16.9×	-8578.3%	43.7%	0.9%	-0.8%	-2.3%	-0.7%	-2.2%	1.34×	8.83×	0.28×	1.09×	0.0%	3	0.3	2	C
DVYSR.STDevyser Diagnostics AB (publ)	SEK 64.90	-223.92×	5.35×	7.56×	49.58×	-193.5%	80.6%	4.2%	-3.4%	-2.4%	2.6%	0.4%	0.15×	-0.68×	0.78×	2.88×	0.0%	7	6.42	2	C+
Peer median	—	-1.17×	2.24×	0.74×	8.99×	-193.5%	17.5%	4.2%	-0.8%	-2.3%	2.6%	0.4%	1.34×	3.92×	0.78×	1.09×	0.0%	6	1.38	2	—